PhRMA Weighs In On FDA Internet and Social Media Guidance Delays
This article was originally published in RPM Report
Executive Summary
FDA has delayed issuing guidance for rules of the road when it comes to promotion of drugs on the internet and through social media platforms. The drug industry’s trade group says if FDA can promote medicines on Twitter, why can’t the manufacturers do the same?